Literature DB >> 26115740

Target lesion calcification and risk of adverse outcomes in patients with drug-eluting stents. A meta-analysis.

Bao-Tao Huang1, Fang-Yang Huang1, Zhi-Liang Zuo1, Wei Liu1, Kai-Sen Huang1, Yan-Biao Liao1, Peng-Ju Wang1, Yong Peng1, Chen Zhang1, Zhen-Gang Zhao1, De-Jia Huang1, Mao Chen2.   

Abstract

BACKGROUND: Studies focusing on the relationship between calcified lesions and adverse outcomes in the drug-eluting stent (DES) era have presented inconsistent conclusions. The aim of this study was to assess the association between target lesion calcification and adverse outcomes in patients undergoing DES implantation.
METHODS: A systematic search was conducted on Medline (Ovid SP, 1946 to 28 February 2014), Embase (Ovid SP, 1974 to 28 February 2014), and the Chinese Biomedical Literature Database (CBM, 1978 to 28 February 2014). Abstracts from the 2012 and 2013 scientific meetings of the American College of Cardiology and American Heart Association were manually searched. Hazard ratios (HRs) were pooled using a fixed or random effects model in the context of heterogeneity.
RESULTS: A total of 13 studies comprising 66,361 patients were included. Target lesion calcification was associated with an increased risk of all-cause mortality (HR = 1.41; 95 % CI = 1.27-1.56), cardiac death (HR = 1.97; 95 % CI = 1.68-2.31), myocardial infarction (HR = 1.33; 95 % CI = 1.13-1.57), target lesion revascularization (TLR; HR 1.47, 95 % CI 1.18-1.83), stent thrombosis (HR 1.63, 95 % CI 1.36-1.96), and major cardiovascular events (HR 1.37, 95 % CI 1.19-1.58). The results proved robust in subgroup analyses for TLR and stent thrombosis.
CONCLUSION: Calcified target lesions are risk factors for adverse outcomes in the DES era. Further studies focusing on comprehensive therapy in patients with coronary calcification are urgently needed.

Entities:  

Keywords:  Coronary artery calcification; Drug-eluting stent; Outcome; Percutaneous coronary intervention; Risk factor

Mesh:

Year:  2015        PMID: 26115740     DOI: 10.1007/s00059-015-4324-1

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  42 in total

1.  Composition of coronary atherosclerotic plaques in patients with acute myocardial infarction and stable angina pectoris determined by contrast-enhanced multislice computed tomography.

Authors:  Alexander W Leber; Andreas Knez; Carl W White; Alexander Becker; Franz von Ziegler; Olaf Muehling; Christoph Becker; Maximilian Reiser; Gerhard Steinbeck; Peter Boekstegers
Journal:  Am J Cardiol       Date:  2003-03-15       Impact factor: 2.778

2.  Percutaneous coronary intervention of moderate to severe calcified coronary lesions: insights from the National Heart, Lung, and Blood Institute Dynamic Registry.

Authors:  Sripal Bangalore; Helen A Vlachos; Faith Selzer; Robert L Wilensky; Kevin E Kip; David O Williams; David P Faxon
Journal:  Catheter Cardiovasc Interv       Date:  2011-01-01       Impact factor: 2.692

3.  Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS.

Authors:  Philippe Généreux; Mahesh V Madhavan; Gary S Mintz; Akiko Maehara; Tullio Palmerini; Laura Lasalle; Ke Xu; Tom McAndrew; Ajay Kirtane; Alexandra J Lansky; Sorin J Brener; Roxana Mehran; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2014-02-19       Impact factor: 24.094

4.  Comparison of electron-beam computed tomography and intracoronary ultrasound in detecting calcified and noncalcified plaques in patients with acute coronary syndromes and no or minimal to moderate angiographic coronary artery disease.

Authors:  A Schmermund; D Baumgart; M Adamzik; J Ge; D Grönemeyer; R Seibel; C Sehnert; G Görge; M Haude; R Erbel
Journal:  Am J Cardiol       Date:  1998-01-15       Impact factor: 2.778

5.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

6.  Success rate of implantation and mid-term outcomes of the sirolimus-eluting stent.

Authors:  Shuji Suzuki; Hiroshi Kamihata; Tetsuya Hata; Fujio Hayashi; Akira Miura; Masahiro Yoshinaga; Masahiro Karakawa; Yasushi Kitaura
Journal:  Circ J       Date:  2007-01       Impact factor: 2.993

7.  In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia.

Authors:  R Kornowski; M K Hong; F O Tio; O Bramwell; H Wu; M B Leon
Journal:  J Am Coll Cardiol       Date:  1998-01       Impact factor: 24.094

8.  Impact of lesion calcification on clinical and angiographic outcome after sirolimus-eluting stent implantation in real-world patients.

Authors:  Ren Kawaguchi; Hideki Tsurugaya; Hiroshi Hoshizaki; Takuji Toyama; Shigeru Oshima; Koichi Taniguchi
Journal:  Cardiovasc Revasc Med       Date:  2008 Jan-Mar

9.  The dilemma of diagnosing coronary calcification: angiography versus intravascular ultrasound.

Authors:  E M Tuzcu; B Berkalp; A C De Franco; S G Ellis; M Goormastic; P L Whitlow; I Franco; R E Raymond; S E Nissen
Journal:  J Am Coll Cardiol       Date:  1996-03-15       Impact factor: 24.094

10.  Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries.

Authors:  John M Lasala; David A Cox; David Dobies; Kenneth Baran; William B Bachinsky; Edwin W Rogers; Jeffrey A Breall; David H Lewis; Aijun Song; Ruth M Starzyk; Stephen R Mascioli; Keith D Dawkins; Donald S Baim
Journal:  Circ Cardiovasc Interv       Date:  2009-07-22       Impact factor: 6.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.